PlainPill

Bupropion

Also known as Wellbutrin, Zyban

The short answer. People are split on Bupropion — 41% of 271 say it helped. It is most often used for mood: 70% of 172 reports say that improved. It is well studied — 411 meta-analyses on PubMed. The most common complaint is anxiety.

What users report
41%helped271 reports · high confidence
111 helped84 mixed75 didn't help

From 444 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
411
meta-analyses
617
RCTs
5,747
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Bupropion does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 411 meta-analyses on PubMed ↗ · 617 randomized trials ↗

Lancet Psychiatry · 2018 · Meta-analysis / systematic review
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

Conclusion: Our findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADHD. New research should be funded urgently to assess long-term effects of these drugs.

PubMed 30097390 ↗
Mol Psychiatry · 2023 · Meta-analysis / systematic review
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis

Conclusion: Compared to placebo, venlafaxine was associated with a lower incidence of dizziness, while desvenlafaxine, sertraline, and vortioxetine were associated with a higher incidence of nausea/vomiting. In conclusion, desvenlafaxine, paroxetine, venlafaxine, and vortioxetine had reasonable efficacy, acceptability, and tolerability in the treatment of adults with stable MDD.

PubMed 36253442 ↗
Registered clinical trials

508 human trials on ClinicalTrials.gov test Bupropion — 368 completed, 26 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

FDA drug label

Boxed warning (the FDA's strongest label warning): “SUICIDAL THOUGHTS AND BEHAVIORS SUICIDALITY AND ANTIDEPRESSANT DRUGS Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. These trials did not show an increase in the risk of suicidal thoughts and behavior with…”

Full label on DailyMed (NIH) ↗

Hidden in other products (FDA)

The FDA found Bupropion as an undeclared ingredient in 1 product sold as supplements, most recently on 2024-10-30. FDA tainted-products database ↗

FDA recalls

39 recalls of products named for Bupropion. Most recent:

  • 2025-10-29 · Class II: Failed Tablet/Capsule Specifications record ↗
  • 2024-07-17 · Class II: Failed Dissolution Specifications; the product is dissolving faster than the specified limits. record ↗
  • 2024-01-17 · Class II: Presence of Foreign Tablets/Capsules record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

140,700 adverse-event reports mention Bupropion. Most often reported:

  • Drug ineffective · 12,623
  • Nausea · 9,835
  • Fatigue · 9,438
  • Headache · 8,846
  • Depression · 8,333
  • Anxiety · 7,199

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Bupropion C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗

US government research funding (NIH)

NIH has funded 60 research projects with Bupropion in the title, $69,337,797 in total (1992–2026). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Bupropion ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

anxiety ×19insomnia ×8irritability ×7tinnitus ×4sexual dysfunction ×4anhedonia ×3rage ×3chest pain ×2

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“It really helped. I went from being suicidal to having hope and motivation within 3 days of starting the medication.”
HelpedRead the discussion ↗
“it might boost neurogenesis and makes me energetic. The drawbacks are higher heart rate and somewhat worse memory.”
MixedRead the discussion ↗
“I've been on welbutrin for off-label ADHD-i treatment for almost 6 years. It's changed everything - keeps me pretty level, keeps me focused.”
HelpedRead the discussion ↗
“Yes tried wellbutrin made me kind of ok then made my ocd worse.”
MixedRead the discussion ↗
Read more Bupropion reviews →
Top discussions (5)

Bupropion compared

Other options for mood

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate